Vedanta’s BALCO Medical Centre leads the vision of a cancer-free India
3rd February 2022
New Delhi; 3rd February, 2022: Vedanta’s BALCO Medical Centre, has emerged as one of India’s top cancer hospitals, and central India’s most preferred cancer care hospital. The BALCO Medical Centre (BMC) is a state-of-the-art 170-bed ultra-modern, multi-modality diagnostic and therapeutic facility hospital in Raipur, Chhattisgarh. The hospital is sought-after for its advanced medical care facilities, renowned oncologists, and affordable & compassionate care to the patients.
BALCO Medical Centre has already made a difference to the lives of lakhs of people, dedicating itself to the three important pillars of prevention, screening and treatment. It is one of the most preferred facilities in the country for advanced radiation therapy, brachytherapy, nuclear medicine, surgeries, chemotherapy, immunotherapy, targeted therapy, blood-related disorders, plastic and reconstructive surgery, and pain & palliative care. The hospital offers many latest technologies in cancer diagnostics and treatment like PSMA & DOTA scan, virtual planning and 3D modelling in head & neck cancer surgeries, CRS & HIPEC, advanced microvascular surgeries, lutetium therapy and allogeneic bone marrow transplant.
The hospital has one of the most modern linear accelerators, the largest day-care unit for chemotherapy, five modern operation theatres and a full-fledged nuclear medical department equipped with the only SPECT CT machine in Chhattisgarh, enabling it to provide precise diagnostics and the best treatment.
With its substantial and impactful work, the hospital is on a mission to help create a cancer-free society, dedicating its expertise and resources to address the country’s massive demand-supply gap in cancer treatment, low awareness, lack of infrastructure and shortage of oncologists. Sharing BALCO Medical Centre’s vision, Mrs. Jyoti Agarwal, Chairperson of BMC, said, “While cancer treatment capabilities in India have increased over the past few decades, most facilities are concentrated around urban pockets. Looking at the rising incidence of cancer as a health threat and lack of quality cancer care centres in tier 2 and 3 cities, Vedanta established BALCO Medical Centre at Naya Raipur to provide affordable comprehensive cancer care to all the sections of the society. We are also leveraging partnerships with like-minded philanthropic organisations and influencers to reduce the treatment burden on people belonging to economically weaker sections.”
BALCO Medical Centre is NABH accredited, a testimony to the quality of its services. Along with cancer treatment, all patients at BALCO Medical Centre also benefit from psychological, nutritional and physical therapy, as well as membership of various patient support groups for emotional support.
“I am very satisfied with the work, attitude, behaviour, knowledge regarding their work and professionalism demonstrated by the BALCO Medical Centre team. They provide medical services and patient care in a very helpful and diligent manner, following proper protocols. Wishing them the best,” says Dr. Neevraj Singh from Chhattisgarh, whose mother Mrs. Priti Singh was treated at the hospital.
On the occasion of World Cancer Day, the hospital re-dedicates itself to be in forefront of fight against cancer, one of mankind’s most dangerous disease, and continue to serve humankind with utmost care and compassion.
About Vedanta Limited:
Vedanta Limited, a subsidiary of Vedanta Resources Limited, is one of the world’s leading Oil & Gas and Metals company with significant operations in Oil & Gas, Zinc, Lead, Silver, Copper, Iron Ore, Steel, and Aluminium & Power across India, South Africa and Namibia. For two decades, Vedanta has been contributing significantly to nation building. Governance and sustainable development are at the core of Vedanta's strategy, with a strong focus on health, safety, and environment. Vedanta has put in place a comprehensive framework to be the ESG leader in the natural resources sector. Vedanta is committed to reducing carbon emissions to zero by 2050 or sooner and has pledged $5 billion over the next 10 years to accelerate the transition to net zero operations. Giving back is in the DNA of Vedanta, which is focused on enhancing the lives of local communities. The company’s flagship social impact program, Nand Ghars, have been set up as model anganwadis focused on eradicating child malnutrition, providing education, healthcare, and empowering women with skill development. Under the aegis of the Anil Agarwal Foundation, the umbrella entity for Vedanta’s social initiatives, the Vedanta group has pledged Rs 5000 crore over the next five years on social impact programmes with a thrust on nutrition, women & child development, healthcare, animal welfare, and grass-root level sports. Vedanta and the group companies have been featured in Dow Jones Sustainability Index, and was conferred Frost & Sullivan Sustainability Awards 2020, Golden Peacock Award for excellence in Corporate Governance 2022 and certified as a Great Place to Work 2022. Vedanta Limited is listed on the Bombay Stock Exchange and the National Stock Exchange.
For more information, please visit www.vedantalimited.com
About Vedanta Aluminium Business:
Vedanta Aluminium, a business of Vedanta Limited, is India’s largest producer of aluminium, manufacturing more than half of India’s aluminium i.e., 2.37 million tonnes in FY24. It is a leader in value-added aluminium products that find critical applications in core industries. Vedanta Aluminium ranks 1st in the S&P Global Corporate Sustainability Assessment 2023 world rankings for the aluminium industry, a reflection of its leading sustainable development practices. With its world-class aluminium smelters, alumina refinery and power plants in India, the company fulfils its mission of spurring emerging applications of aluminium as the ‘Metal of the Future’ for a greener tomorrow.
For more information, please log on to www.vedantaaluminium.com
Follow us on LinkedIN, Facebook, Twitter, Instagram
Disclaimer:
This press release contains “forward-looking statements” – that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “should” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. For us, uncertainties arise from the behaviour of financial and metals markets including the London Metal Exchange, fluctuations in interest and or exchange rates and metal prices; from future integration of acquired businesses; and from numerous other matters of national, regional, and global scale, including those of a political, economic, business, competitive or regulatory nature. These uncertainties may cause our actual future results to be materially different than those expressed in our forward-looking statements. We do not undertake to update our forward-looking statements.
